| Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs CJH Porter, NL Trevaskis, WN Charman Nature reviews Drug discovery 6 (3), 231-248, 2007 | 1546 | 2007 |
| Strategies to address low drug solubility in discovery and development HD Williams, NL Trevaskis, SA Charman, RM Shanker, WN Charman, ... Pharmacological reviews 65 (1), 315-499, 2013 | 1077 | 2013 |
| Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies CW Pouton, CJH Porter Advanced drug delivery reviews 60 (6), 625-637, 2008 | 824 | 2008 |
| Enhancing intestinal drug solubilisation using lipid-based delivery systems CJH Porter, CW Pouton, JF Cuine, WN Charman Advanced drug delivery reviews 60 (6), 673-691, 2008 | 685 | 2008 |
| Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH WN Charman, CJH Porter, S Mithani, JB Dressman Journal of pharmaceutical sciences 86 (3), 269-282, 1997 | 670 | 1997 |
| Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine SM Khoo, AJ Humberstone, CJH Porter, GA Edwards, WN Charman International journal of pharmaceutics 167 (1-2), 155-164, 1998 | 486 | 1998 |
| In vitro assessment of oral lipid based formulations CJH Porter, WN Charman Advanced drug delivery reviews 50, S127-S147, 2001 | 428 | 2001 |
| Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update NL Trevaskis, WN Charman, CJH Porter Advanced drug delivery reviews 60 (6), 702-716, 2008 | 355 | 2008 |
| Intestinal lymphatic drug transport: an update CJH Porter, WN Charman Advanced drug delivery reviews 50 (1-2), 61-80, 2001 | 339 | 2001 |
| Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating SM Moghimi, CJH Porter, IS Muir, L Illum, SS Davis Biochemical and biophysical research communications 177 (2), 861-866, 1991 | 322 | 1991 |
| Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility DB Warren, H Benameur, CJH Porter, CW Pouton Journal of drug targeting 18 (10), 704-731, 2010 | 288 | 2010 |
| Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products L Sek, CJH Porter, AM Kaukonen, WN Charman Journal of pharmacy and pharmacology 54 (1), 29-41, 2002 | 283 | 2002 |
| From sewer to saviour—targeting the lymphatic system to promote drug exposure and activity NL Trevaskis, LM Kaminskas, CJH Porter Nature Reviews Drug Discovery 14 (11), 781-803, 2015 | 281 | 2015 |
| Effect of short‐, medium‐, and long‐chain fatty acid‐based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of … SM Caliph, WN Charman, CJH Porter Journal of pharmaceutical sciences 89 (8), 1073-1084, 2000 | 273 | 2000 |
| Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation CJH Porter, AM Kaukonen, BJ Boyd, GA Edwards, WN Charman Pharmaceutical research 21 (8), 1405-1412, 2004 | 253 | 2004 |
| Lymphatic transport of proteins after subcutaneous administration CJH Porter, SA Charman Journal of pharmaceutical sciences 89 (3), 297-310, 2000 | 237 | 2000 |
| The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow CJH Porter, SM Moghimi, L Illum, SS Davis FEBS letters 305 (1), 62-66, 1992 | 215 | 1992 |
| 50 years of oral lipid-based formulations: provenance, progress and future perspectives OM Feeney, MF Crum, CL McEvoy, NL Trevaskis, HD Williams, ... Advanced drug delivery reviews 101, 167-194, 2016 | 206 | 2016 |
| Minimum information reporting in bio–nano experimental literature M Faria, M Björnmalm, KJ Thurecht, SJ Kent, RG Parton, M Kavallaris, ... Nature nanotechnology 13 (9), 777-785, 2018 | 201 | 2018 |
| Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine CJH Porter, AM Kaukonen, A Taillardat-Bertschinger, BJ Boyd, ... Journal of pharmaceutical sciences 93 (5), 1110-1121, 2004 | 200 | 2004 |
